Latest news
Business Update
Kopfwehzentrum Hirslanden joins Priority Access Program
We are happy to welcome the Kopfwehzentrum Hirslanden as an early adopter of our Priority Access Program for migraine patients!
04 December, 2024
Read more
Business Update | Fri 12, 2021
Bottneuro wins CHF 150,000 to advance diagnosis and digital therapies for Alzheimer’s disease
Business Update | Mon 11, 2021
Switzerland advances personalized Alzheimer’s therapy
Tokyo (SCCIJ) – The two Swiss-based companies Positrigo and Bottneuro have joined forces to foster the early diagnosis and personalized treatment of A...
Business Update | Thu 11, 2021
BottNeuro advancing personalized alzheimer’s therapy
Bottneuro is working on the development of personalized therapies to treat Alzheimer’s disease in which certain areas of a patient’s brain are stimula...
Featured news
